Skip to main content
. 2010 Jun 29;299(5):E713–E720. doi: 10.1152/ajpendo.00279.2010

Fig. 1.

Fig. 1.

Glucose tolerance test in “nude” rats at 18 wk following either epididymal fat pad or TheraCyte device pancreatic endoderm implantation. A–C: individual data points for glucose, human insulin, and human C-peptide at fasting (fast) and 30 min after intraperitoneal (ip) glucose injection in nude rats implanted with pancreatic endoderm into the epididymal fat pad. D–F: individual data points for glucose, human insulin, and human C-peptide at fasting and 30 min after ip glucose injection in nude rats with subcutaneously implanted pancreatic endoderm in TheraCyte devices.